Skip to main content
  • 329 Accesses

Abstract

Since Biotechnology emerged as a business in the late 1970s the emphasis has shifted from the early predictions1 that the money makers would be a new generation of raw biochemicals and enzymes to diagnostics and pharmaceuticals, based on the key technologies of monoclonal antibodies and genetic engineering. The over-riding factor here is return on investment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. European Chemical News 27.4.81, p.12

    Google Scholar 

  2. Bio/Technology, April 1984, p.312

    Google Scholar 

  3. Scrip No. 645, 23rd November, 1981, p.8

    Google Scholar 

  4. Biotechnology Bulletin, April 1984, Report No. 47

    Google Scholar 

  5. D. Fishlock, Country cousins of biotechnology, Financial Times, 12th June 1984, p. 14

    Google Scholar 

  6. Anon., Recombinant DNA: Economic Study Predicts Limited Future, Gen. Eng. News, March/April 1983, p.19

    Google Scholar 

  7. Bio/Technology, August 1984, p.667

    Google Scholar 

  8. New Scientist 10.11.83, p.419

    Google Scholar 

  9. Scrip No. 1124, 30 July 1986, p.20

    Google Scholar 

  10. New Scientist, 28 July 1983

    Google Scholar 

  11. S. Connor, Gene probes find Huntington’s disease, New Scientist, Nov. 1983, p.399

    Google Scholar 

  12. Hospital Doctor, 8 March 1984

    Google Scholar 

  13. Radio 4, Medicine Now, 19.9.84, 13a Inpharma 2nd Aug 1986:3

    Google Scholar 

  14. B. Johnstone, Laser Speeds Up Genetic Engineering, New Scientist, 10th Nov. 1983, p.643

    Google Scholar 

  15. The Guardian, 6 September 1984, p. 14

    Google Scholar 

  16. Anon., New club beefs up protein research, New Scientist, 1st Dec. 1983, p.643

    Google Scholar 

  17. G. Colverd, A light blue sugar sensor, Sunday Telegraph, 16th Oct. 1983, p.12

    Google Scholar 

  18. Chemistry & Industry, 2.4.84, p.233

    Google Scholar 

  19. European Chemical News Chemscope, May 1984

    Google Scholar 

  20. Science 221, p.953

    Google Scholar 

  21. Rimmington, Bulletin of the Biotechnology Centre, Wales, Article 16:3:8

    Google Scholar 

  22. Financial Times, 8 March 1983

    Google Scholar 

  23. Times, 2 August, 1983

    Google Scholar 

  24. New Scientist, 6 September, 1982, p.7

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Copyright information

© 1988 The Editor and the Contributors

About this chapter

Cite this chapter

Llewelyn, J. (1988). Futures for Biotechnology. In: Greenshields, R. (eds) Resources and Applications of Biotechnology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-09574-2_39

Download citation

Publish with us

Policies and ethics